Silverstone T
Clin Ther. 1981;3(5):374-81.
In a double-blind clinical trial conducted in general practice, maprotiline was compared with amitriptyline. Thirty-three of 40 patients completed the trial, 19 on maprotiline and 14 on amitriptyline. The Hamilton Depression Rating Scale was administered on days, 0, 7, 14, and 21, and a global rating scale of improvement was administered on day 21. Although there were significant reductions in the Hamilton scores by day 21 in both groups, with no significant difference between the compounds, maprotiline produced significantly greater improvement by day 7 than did amitriptyline. A review of published double-blind clinical amitriptyline or imipramine for treatment of depression supports our finding that maprotiline has a faster onset of action than the standard tricyclic antidepressants.
在一项在普通医疗实践中进行的双盲临床试验中,将马普替林与阿米替林进行了比较。40名患者中有33名完成了试验,19名服用马普替林,14名服用阿米替林。在第0、7、14和21天使用汉密尔顿抑郁评定量表,并在第21天使用总体改善评定量表。尽管两组在第21天时汉密尔顿评分均有显著降低,且两种药物之间无显著差异,但马普替林在第7天时产生的改善明显大于阿米替林。对已发表的关于使用阿米替林或丙咪嗪治疗抑郁症的双盲临床试验的综述支持了我们的发现,即马普替林的起效速度比标准三环类抗抑郁药更快。